Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-10 10:25 am Sale | 2024-12-31 | 13G | Exact Sciences Corporation EXAS | WELLINGTON MANAGEMENT CO LLP | 12,394,303 6.700% | -2,258,555 (-15.41%) | Filing History |
| 2024-11-13 2:58 pm Purchase | 2024-11-07 | 13G | Exact Sciences Corporation EXAS | Capital World Investors | 15,841,296 8.600% | 11,158,446 (+238.28%) | Filing History |
| 2024-11-08 10:52 am Purchase | 2024-09-30 | 13G | Exact Sciences Corporation EXAS | WELLINGTON MANAGEMENT CO LLP | 14,652,858 7.930% | 4,116,099 (+39.06%) | Filing History |
| 2024-10-07 11:37 am Purchase | 2024-10-04 | 13G | Exact Sciences Corporation EXAS | FMR LLC | 22,042,464 11.897% | 19,419,703 (+740.43%) | Filing History |
| 2024-10-04 4:00 pm Purchase | 2024-09-27 | 13G | MDxHealth SA MDXH | EXACT SCIENCES CORP EXAS | 3,441,171 7.100% | 3,441,171 (New Position) | Filing History |
| 2024-06-07 12:07 pm Sale | 2024-05-31 | 13G | Exact Sciences Corporation EXAS | JPMORGAN CHASE & CO JPM | 7,521,686 4.000% | -9,820,316 (-56.63%) | Filing History |
| 2024-02-13 5:04 pm Purchase | 2023-12-29 | 13G | Exact Sciences Corporation EXAS | The Vanguard Group | 17,559,751 9.710% | 307,286 (+1.78%) | Filing History |
| 2024-02-09 08:40 am Purchase | 2023-12-29 | 13G | Exact Sciences Corporation EXAS | WELLINGTON MANAGEMENT CO LLP | 10,536,759 5.830% | 132,283 (+1.27%) | Filing History |
| 2024-01-29 5:25 pm Sale | 2023-12-31 | 13G | Exact Sciences Corporation EXAS | BlackRock Inc. BLK | 11,103,191 6.100% | -250,943 (-2.21%) | Filing History |
| 2024-01-23 09:40 am Sale | 2023-12-29 | 13G | Exact Sciences Corporation EXAS | JPMORGAN CHASE & CO JPM | 17,342,002 9.500% | -1,310,294 (-7.02%) | Filing History |
| 2023-10-10 1:51 pm Purchase | 2023-09-29 | 13G | Exact Sciences Corporation EXAS | JPMORGAN CHASE & CO JPM | 18,652,296 10.300% | 18,652,296 (New Position) | Filing History |
| 2023-02-10 12:31 pm Purchase | 2022-12-31 | 13G | Exact Sciences Corporation EXAS | ARK Investment Management LLC | 16,040,490 9.030% | 2,544,476 (+18.85%) | Filing History |
| 2023-02-09 11:19 am Purchase | 2022-12-30 | 13G | Exact Sciences Corporation EXAS | The Vanguard Group | 17,252,465 9.710% | 1,820,731 (+11.80%) | Filing History |
| 2023-02-07 10:43 am Purchase | 2022-12-31 | 13G | Exact Sciences Corporation EXAS | BlackRock Inc. BLK | 11,354,134 6.400% | 1,857,122 (+19.55%) | Filing History |
| 2023-02-06 2:51 pm Sale | 2022-12-30 | 13G | Exact Sciences Corporation EXAS | WELLINGTON MANAGEMENT CO LLP | 10,404,476 5.860% | -720,921 (-6.48%) | Filing History |
| 2022-09-12 2:07 pm Sale | 2022-08-31 | 13G | Exact Sciences Corporation EXAS | PRICE T ROWE ASSOCIATES INC | 6,464,337 3.700% | -12,260,399 (-65.48%) | Filing History |
| 2022-03-10 12:48 pm Purchase | 2022-02-28 | 13G | Exact Sciences Corporation EXAS | PRICE T ROWE ASSOCIATES INC | 18,724,736 10.700% | 4,936,603 (+35.80%) | Filing History |
| 2022-02-14 2:34 pm Sale | 2021-12-31 | 13G | Exact Sciences Corporation EXAS | PRICE T ROWE ASSOCIATES INC | 13,788,133 8.000% | -2,764,957 (-16.70%) | Filing History |
| 2022-02-11 2:48 pm Sale | 2022-02-14 | 13G | Exact Sciences Corporation EXAS | Capital World Investors | 4,682,850 2.700% | -5,615,546 (-54.53%) | Filing History |
| 2022-02-10 08:11 am Purchase | 2021-12-31 | 13G | Exact Sciences Corporation EXAS | The Vanguard Group | 15,431,734 8.960% | 1,231,641 (+8.67%) | Filing History |